Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?

By W. Whitehead, O. Palsson, Kenneth r. Jones. Gastroenterology, 2002

1,114 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Anxiety disorders and comorbid medical illness. (2008, neutral): “[32] Whitehead WE, Palsson O, Jones KR.”
Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects (2010, positive): “For example, inflammatory bowel disease was associated with mood disorders in more than 50 % of patients, but with more pronounced psychological disturbances during periods of active intestinal distress((21,22)).”
Gut microbiota in health and disease. (2010, background): “(333), who found that between 30 and 75% of affected patients exhibited symptoms of somatic hypersensitivity, which is also common among IBS patients (34).”
The epidemiology of irritable bowel syndrome (2014, background): “Multivariate analysis supports the idea that somatic comorbidities seen in IBS are distinct disorders and not manifestations of one somatization disorder.(118) Even so, patients who have IBS and other somatic comorbidities report more severe symptoms than those patients with IBS alone.”